Swept source optical coherence tomography analysis of choroidal thickness in macular telangiectasia type 2: a case-control study.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 30 06 2018
accepted: 06 12 2018
revised: 24 11 2018
pubmed: 19 12 2018
medline: 11 4 2019
entrez: 19 12 2018
Statut: ppublish

Résumé

There has been a recent interest in the association of macular telangiectasia (MacTel) type 2 with central serous choroidopathy and other pachychoroid disorders. This study was performed to assess the subfoveal choroidal thickness (SFCT) in patients with MacTel type 2 and compare it with healthy controls using swept source optical coherence tomography (SS-OCT). It was a retrospective case-control study performed at a tertiary eye care center. The cases constituted patients with MacTel type 2 detected over the last 2 years (April 2016 to March 2018). The controls were healthy adults with no posterior segment pathology. The patients were evaluated with color fundus photography, SS-OCT (Triton, Topcon Inc., Oakland, New Jersey, USA) and fundus fluorescein angiography. The cases were staged based on Gass and Blodi classification. SFCT was compared between the two groups. Sixty-five eyes of 33 patients with MacTel were included. The controls consisted of 61 eyes of 33 healthy age-matched (p = 0.81) and sex-matched (p = 0.31) adults. The mean SFCT in cases (353.0 ± 91.2 μm) was higher than controls (289.2 ± 69.0 μm), and this difference was statistically significant (p = 0.0001). The mean SFCT was different in various stages: 346.6 ± 86.3 μm (stage 2), 334.6 ± 90.2 μm (stage 3), 374.6 ± 94.0 μm (stage 4), and 294.8 ± 68.8 μm (stage 5), though this was not statistically significant (p = 0.28). The choroid in MacTel type 2 patients was significantly thickened as compared to controls. SFCT may vary as the structural changes worsen over time.

Identifiants

pubmed: 30560414
doi: 10.1007/s00417-018-04215-9
pii: 10.1007/s00417-018-04215-9
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

567-573

Références

Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3117-23
pubmed: 10967072
J Biomed Opt. 2005 Jul-Aug;10(4):44009
pubmed: 16178643
Prog Retin Eye Res. 2006 Jul;25(4):397-424
pubmed: 16839797
Arch Ophthalmol. 2006 Oct;124(10):1410-9
pubmed: 17030708
Retina. 2007 Nov-Dec;27(9):1214-20
pubmed: 18046227
Am J Ophthalmol. 2008 Oct;146(4):496-500
pubmed: 18639219
Am J Ophthalmol. 2009 Sep;148(3):445-50
pubmed: 19541286
Retina. 2009 Nov-Dec;29(10):1469-73
pubmed: 19898183
Prog Retin Eye Res. 2010 Mar;29(2):144-68
pubmed: 20044062
Retina. 2011 Sep;31(8):1603-8
pubmed: 21487334
Prog Retin Eye Res. 2013 May;34:49-77
pubmed: 23219692
Curr Opin Ophthalmol. 2013 May;24(3):213-21
pubmed: 23429598
Ophthalmology. 2013 Nov;120(11):2344-52
pubmed: 23769334
Ophthalmologica. 2013;230(3):126-30
pubmed: 23969580
Invest Ophthalmol Vis Sci. 2013 Nov 19;54(12):7630-6
pubmed: 24168999
Br J Ophthalmol. 2014 Mar;98(3):334-8
pubmed: 24288394
Am J Ophthalmol. 2014 Jun;157(6):1272-1281.e1
pubmed: 24561169
Retina. 2014 Aug;34(8):1560-6
pubmed: 24732697
Saudi J Ophthalmol. 2014 Apr;28(2):123-8
pubmed: 24843305
Retina. 2014 Sep;34(9):1819-23
pubmed: 24896138
Biomed Res Int. 2014;2014:639160
pubmed: 25013793
Br J Ophthalmol. 2015 Mar;99(3):354-8
pubmed: 25273828
Indian J Ophthalmol. 2014 Nov;62(11):1060-1063
pubmed: 25494246
Ophthalmic Surg Lasers Imaging Retina. 2015 Feb;46(2):162-70
pubmed: 25707040
Eur J Ophthalmol. 2016 Mar-Apr;26(2):145-51
pubmed: 26428218
Clin Ophthalmol. 2016 Nov 14;10:2271-2276
pubmed: 27881909
Indian J Ophthalmol. 2017 Jun;65(6):516-517
pubmed: 28643718
Retina. 2018 Jan;38 Suppl 1:S67-S78
pubmed: 29016451
Eur J Ophthalmol. 2018 Apr 1;:1120672118769527
pubmed: 29676172
Ophthalmology. 1993 Oct;100(10):1536-46
pubmed: 8414413

Auteurs

Vinod Kumar (V)

Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Devesh Kumawat (D)

Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. deveshkumawat21@gmail.com.

Pradeep Kumar (P)

Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH